Dec 20, 2011
Genmab Announces Progress with DuoBody™ Platform
Dec 15, 2011
Genmab Announces Progress with Lundbeck Collaboration
Dec 10, 2011
Genmab Announces Preliminary Safety and Efficacy Data for Daratumumab
Dec 8, 2011
Grant of Warrants to Employees in Genmab
Dec 8, 2011
Genmab’s Financial Calendar for 2012
Dec 6, 2011
Genmab Announces Appeal of US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
Nov 17, 2011
Genmab Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
Nov 8, 2011
Multiple Data for Ofatumumab and Daratumumab to be presented at ASH
Nov 2, 2011
Genmab Announces Financial Results for the First Nine Months of 2011 and Updated 2011 Financial Guidance
Oct 26, 2011
Arzerra Third Quarter 2011 Net Sales Figures
Oct 14, 2011
Grant of Warrants to Employees in Genmab
Sep 7, 2011
Genmab to Present at Two Investor Conferences in September
Aug 5, 2011
Genmab Announces Top-Line Phase II Results for Ofatumumab Combined with Chemotherapy in Second Line Aggressive Lymphoma
Aug 3, 2011
Genmab Announces Financial Results for the First Half of 2011 and Improved Guidance
Jul 26, 2011
Arzerra Second Quarter 2011 Net Sales Figures
Jun 24, 2011
Genmab Announces Zalutumumab Update
Jun 22, 2011
Grant of Warrants to Board Members, Management and Employees in Genmab
May 25, 2011
Genmab to Attend Two June Investor Conferences
May 11, 2011
Genmab Announces Financial Results for the First Quarter 2011
Apr 27, 2011
Genmab Announces Appointment of Rachel Curtis Gravesen as New Head of Investor Relations
Apr 27, 2011
Arzerra First Quarter 2011 Net Sales Figures
Apr 19, 2011
Genmab and Seattle Genetics Expand Antibody-Drug Conjugate Collaboration
Apr 6, 2011
Constitution of the Board of Directors in Genmab A/S and Grant of Warrants to a Board Member and Employees
Apr 6, 2011
Passing of Genmab A/S’ Annual General Meeting
Mar 15, 2011
Genmab A/S Summons Annual General Meeting
Mar 7, 2011
Genmab to Attend Multiple Investor Conferences in March
Feb 28, 2011
Genmab Announces Year End 2010 Financial Results and 2011 Guidance
Feb 24, 2011
Genmab to Attend Credit Suisse One-On-One Healthcare Conference
Feb 3, 2011
Arzerra Fourth Quarter and Full Year 2010 Net Sales Figures
Jan 20, 2011
Genmab Provides Detailed Pipeline and Technology Update at Today’s R&D Day